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developing dementia and rapid cognitive
decline, and DLB.1 2 Similar VH are also
reported in CBS, which was originally
observed in elderly and visually impaired
people without psychiatric or neurological
problems. However, a close resemblance
between CBS and PD related VH is also
suggested.1
Recent neuropathological and radiological
studies revealed that VH in CBS are asso-
ciated with hyperperfusion of the temporal
cortex, striatum, and thalamus, as well as
increased cerebral activation in the ventral
extrastriatal region, while DLB patients with
VH showed hypoperfusion or hypometabo-
lism of the occipital cortex.1 It was also
reported that PD patients with VH also have
alterations in or decreased cerebral activation
in the temporo-parietal, parietal, and occipi-
tal regions.1 Our patient showed atrophy of
the bilateral parieto-occipital, occipital, and
mild left temporal lobes and decreased
cerebral perfusion in the parietal and frontal
lobes, indicating that the VH in our case may
be caused by dysfunction of these regions.
Such VH are rarely experienced by normal
people, but, once seen, some people may be
convinced they are supernatural events. We
neurologists pay attention to such reports,
and note the similarity in content between
ghost tales and VH, and pursue their
mechanism of origin.
In conclusion, we propose that some ghost
sightings are actually VH in normal people,
which occur very rarely but more frequently
than we in the medical establishment think.
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Glucose metabolism and
dopamine PET correlates in a
patient with myotonic dystrophy
type 2 and parkinsonism
We describe a 72 year old woman who
presented with a 5 year history of progressive
gait uncertainty, frequent sudden falls, and
difficulty rising from a chair, associated with
fatigue. She noticed some degree of distal
weakness in her arms when carrying weight
compared with previous years. She had no
complaints of pain or cramps but noticed
stiffness and ‘locked’ legs when walking. She
denied cranial nerve problems and had no
general systemic complaints. Past medical
history was significant for hypertension.
Family history was unremarkable.
Examination revealed normal vital signs
and intact cranial nerves. Slow and slightly
slurred speech was evident. Her trunk was
forcefully bent forwards in a camptocormic
attitude, which could be corrected by passive
extension of the trunk. Her tone was
increased with rigid wrist and hips and brisk
(3+) reflexes and an equivocal bilateral
extensor toe sign. Her gait was slow, and
worsened during the day and over time to the
extent that it limited everyday activities and
often culminated in sudden falls. Pendular
movements were reduced on the left. She had
mild weakness in the shoulder abductors (4),
finger flexors (4.5), hip flexors (4), and ankle
dorsiflexors (4). Sensory examination and
coordination were normal.
Routine blood investigation was unre-
markable except for red blood cells
(3.846106), haemoglobin (11.2 mg/dl) and
haematocrit (34%) in the low normal range.
Gammaglobulins were 7% of total protein
levels. Electrocardiography revealed first
degree arteriovenous block. Brain computed
tomography scan demonstrated diffuse white
matter vascular hypodensity and cortical
atrophy. A diagnosis of parkinsonism was
made. Treatment with Sinemet CR tablets
(carbidopa/levodopa 25/100 mg twice daily)
was started. However, despite treatment, the
patient had not improved 5 months later.
Muscle pain was present. Repeat examina-
tion showed severe neck flexor weakness
(Medical Research Council scale ,3).
The patient was unable to turn on her side
in bed, or to lift her trunk from the bed when
lying. Laboratory examination was
unchanged except for a two fold increase in
creatinine kinase (CK) levels. Needle electro-
myography (EMG) demonstrated diffuse
myotonic discharges. Posterior iridescent
initial cataract was demonstrated by slit lamp
examination in the lens of the left eye.
Fluorescent in situ hybridisation on muscle
biopsy of the left biceps brachii demonstrated
preferential nuclear clump type II fibre
atrophy and ribonuclear inclusions, consis-
tent with the diagnosis of myotonic dystro-
phy type 2 (DM2). (CTG)n expansion at the
DMPK gene was normal. The DM2 mutation
was confirmed and diagnosis of DM2 was
subsequently made.
Neuropsychological tests were adminis-
tered as previously described.1 These included
a screening test for dementia (Mini Mental
State Examination) and tests of nonverbal
reasoning (Raven’s progressive coloured
matrices), auditory language comprehension
(Token test), verbal fluency with phonemic
and semantic cues, verbal and spatial short
term memory (Digit span forward and Spatial
span), verbal and spatial long term memory
(Story recall and Rey recall), constructional
abilities (Rey’s complex copy), attention and
executive function (Trail Making A and B,
Alertness and divided attention, Tower of
London test, Wisconsin Card Sorting test).
The patient showed an impairment of spatial
long term memory (Rey recall: raw score 1
out of 36, cut off of normative data 9.97 out
of 36) and of attention and executive func-
tion (Divided attention: raw score 892 ms;
cut off 811.7 ms), and Tower of London test
(percentage error 193%, cut off 100%). In the
other tests, the patient’s performances were
normal.
Patient details are published with consent
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Figure 1 Statistical parametric maps of 18F-FDG PET showing significant metabolic reductions
(p,0.05 corrected) bilaterally in superior temporal gyrus and parietal operculum (Montreal
Neurological Institute stereotactic coordinates of local maxima for suprathreshold clusters x, y,
z = 64, 228, 10, Z = 6.01; 262, 222, 6, Z = 5.26), and thalamus (18, 222, 14, Z = 5.06; 28,
216, 12, Z = 4.23), superimposed on the T2 weighted MRI of the patient. The areas indicated in
shades of yellow and red both indicate areas of hypoperfusion; yellow represents areas of
maximum hypoperfusion.
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Brain magnetic resonance imaging (MRI)
demonstrated diffuse white matter lesions
consistent with chronic hypoperfusion.1 The
patient then underwent positron emission
tomography (PET) studies with different
tracers: 18F-FDG PET showed a reduction of
glucose metabolism bilaterally in the superior
temporal gyrus, parietal operculum, and,
noteworthy, in the posterior thalamus
(fig 1). The presynaptic dopamine reuptake
as measured by 11C-b-CIT-FE2 and the post-
synaptic D2 receptor density as measured by
11C-raclopride3 were both within the normal
range values, thus revealing the integrity of
the nigrostriatal pathway.
DISCUSSION
Our results confirm initial and more recent
reports that extrapyramidal signs of different
degrees may be present in DM2,2 5 yet
emphasise that the diagnosis of DM2 is still
often one of exclusion and is frequently
unrecognised. Despite the growing number
of reports describing the concomitant find-
ings of myotonic dystrophy and extrapyrami-
dal signs, the frequency and significance of
this association is still unclear. Still less clear
is the pathophysiology of extrapyramidal
involvement and its therapeutic indications.
We describe a patient having camptocor-
mia, bradykinesia, reduction of pendular
movement and rigidity, suggesting features
of Parkinson’s disease (PD). This diagnosis
was only subsequently excluded when there
was no response to levodopa treatment,
weakness and ‘locking’ worsened, and pain
became a dominant symptom. Elevated CK
and myotonic discharges led to the clinical
diagnosis, subsequently confirmed by genetic
analysis. Rigid spine syndrome was consid-
ered as a differential diagnosis because the
bent spine attitude may result from weakness
of the paraspinal and abdominal muscles, as
in this patient. In addition, CK may be
elevated and EMG may show spontaneous
activity and a myopathic pattern. However,
inflammatory signs on muscle biopsy are
prominent in focal myositis, while other
extrapyramidal signs such as those present
in our patient are usually absent.
Although only carried out in a single
patient, our PET studies demonstrate that
parkinsonian features in DM2 are not related
to neurodegenerative processes of the nigro-
striatal system, such as in PD. Instead, they
may be related to hypometabolism in the
posterior thalamus. Studies on a larger group
of patients with DM2 having extrapyramidal
signs are needed to confirm these preliminary
findings demonstrating the integrity of the
dopaminergic system, and the therapeutic
and prognostic implications.
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BOOK REVIEW
Dementia with Lewy Bodies (DLB) is a rare
disorder? It was, but not anymore..!
Following the publication of diagnostic cri-
teria for DLB in 1996, research on this
disorder witnessed a true explosion and the
number of papers published each year
increased by ten-folds. The wealth of knowl-
edge that has been accumulating over the
past 10 years on different aspects of DLB is
now compiled in an easy-to-read volume. The
book is systematically designed—an insight-
ful first chapter on historical aspects is
followed by a general overview on clinical
spectrum of conditions which share Lewy
bodies as their common pathological denomi-
nator and their classification. Authoritative
sections on various aspects of the disease
pursue including epidemiology, individual
sections on cognitive, behavioural, somatic
neurological and autonomic features, as well
as the natural course of the disease, findings
in neuro-imaging, underlying pathology and
neurochemical deficits, and pharmacological
and non-pharmacological treatment
approaches. Some chapters provide compar-
ison to a closely related disorder, dementia
associated with Parkinson’s disease, which is
at the end also covered in a chapter of its
own, along with a chapter devoted to
differentiation of DLB from other disorders
that may cause dementia and parkinsonism.
Most sections are exhaustive with extensive
coverage of the literature. Especially sobering
is a first-hand account of how the disease is
experienced by a caregiver, which would help
clinicians to understand the real difficulties
and set management priorities.
It was timely that the large amount of data
that has been produced in the past decade
was put together in a single volume, espe-
cially so as this has been largely missing. This
is an excellent piece of work that will fill that
gap, with chapters written by authors who
have been in the forefront of research in this
field. The timing is also fitting as revised
diagnostic guidelines on DLB have just been
published. This book will be a useful reading
as well as an excellent source on the large
amount of literature for those who have an
interest in dementia, movement disorders
and the border zone between them.
M Emre
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